Mizoribine Treatment of Young Patients with Severe Lupus Nephritis: A Clinicopathologic Study by the Tohoku Pediatric Study Group

Publisher： Karger

E-ISSN： 1660-2110|110|2|c73-c79

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.110, Iss.2, 2008-09, pp. : c73-c79

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Tacrolimus-Based Immunosuppressive Treatment for Young Patients with Lupus Nephritis: A Prospective Study in Daily Clinical Practice

By  

Nephron Clin Pract, Vol. 121, Iss. 3-4, 2013-01 ,pp. : c165-c173

Karger

Access to resources Recommend Favorite

Treatment of Lupus Nephritis With Abatacept: The Abatacept and Cyclophosphamide Combination Efficacy and Safety Study

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 11, 2014-11 ,pp. : 3096-3104

John Wiley & Sons Inc

Access to resources Recommend Favorite

Does Renin‐Angiotensin System Blockade Protect Lupus Nephritis Patients From Atherosclerotic Cardiovascular Events? A Case–Control Study

By  

ARTHRITIS CARE AND RESEARCH, Vol. 68, Iss. 10, 2016-10 ,pp. : 1497-1504

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: A report from the children's oncology group

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 3, 2015-03 ,pp. : 440-444

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Predictors of Severe Cetuximab-Induced Rash: Observations from 933 Patients Enrolled in North Central Cancer Treatment Group Study N0147

By  

Oncology, Vol. 77, Iss. 2, 2009-07 ,pp. : 120-123

Karger

Access to resources Recommend Favorite